S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20
S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20
S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20
S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20
NYSE:RBOT

Vicarious Surgical Stock Forecast, Price & News

$12.80
+0.06 (+0.47%)
(As of 11/26/2021 12:00 AM ET)
Add
Compare
Today's Range
$12.19
$12.89
50-Day Range
N/A
52-Week Range
$9.50
$15.79
Volume
102,858 shs
Average Volume
381,827 shs
Market Capitalization
$1.52 billion
P/E Ratio
N/A
Dividend Yield
N/A
Beta
-2.01
30 days | 90 days | 365 days | Advanced Chart
Receive RBOT News and Ratings via Email

Sign-up to receive the latest news and ratings for Vicarious Surgical and its competitors with MarketBeat's FREE daily newsletter.


About Vicarious Surgical

D8 Holdings Corp. is a recently formed company whose business purpose is merger and acquisitions in the consumer sector. The company's objective is to identify a target business that is under-valued relative to its potential and ready for transformative improvement.

Headlines

Vicarious Surgical Inc Class A
November 7, 2021 |  realmoney.thestreet.com
RBOT.N - Vicarious Surgical Inc Profile | Reuters
October 21, 2021 |  reuters.com
See More Headlines

Industry, Sector and Symbol

Industry
Surgical appliances & supplies
Sub-Industry
N/A
Sector
Medical
Phone
N/A
Fax
N/A
Employees
3
Year Founded
N/A

Sales & Book Value

Annual Sales
N/A
Book Value
$0.08 per share

Profitability

Pretax Margin
N/A

Debt

Price-To-Earnings

Miscellaneous

Free Float
N/A
Market Cap
$1.52 billion
Optionable
Optionable

Company Calendar

Last Earnings
11/08/2021
Today
11/28/2021
Fiscal Year End
12/31/2021
Next Earnings (Estimated)
2/14/2022

MarketRank

Overall MarketRank

1.50 out of 5 stars

Medical Sector

1074th out of 1,391 stocks

Surgical Appliances & Supplies Industry

21st out of 27 stocks

Analyst Opinion: 2.5Community Rank: 5.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -












Vicarious Surgical (NYSE:RBOT) Frequently Asked Questions

Is Vicarious Surgical a buy right now?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Vicarious Surgical in the last year. There are currently 3 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" Vicarious Surgical stock.
View analyst ratings for Vicarious Surgical
or view top-rated stocks.

When is Vicarious Surgical's next earnings date?

Vicarious Surgical is scheduled to release its next quarterly earnings announcement on Monday, February 14th 2022.
View our earnings forecast for Vicarious Surgical
.

How were Vicarious Surgical's earnings last quarter?

Vicarious Surgical Inc (NYSE:RBOT) issued its quarterly earnings results on Monday, November, 8th. The company reported ($0.09) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.04) by $0.05.
View Vicarious Surgical's earnings history
.

What price target have analysts set for RBOT?

3 brokers have issued 12 month target prices for Vicarious Surgical's stock. Their forecasts range from $15.00 to $16.00. On average, they anticipate Vicarious Surgical's stock price to reach $15.33 in the next twelve months. This suggests a possible upside of 19.8% from the stock's current price.
View analysts' price targets for Vicarious Surgical
or view top-rated stocks among Wall Street analysts.

What is Vicarious Surgical's stock symbol?

Vicarious Surgical trades on the New York Stock Exchange (NYSE) under the ticker symbol "RBOT."

Who are Vicarious Surgical's major shareholders?

Vicarious Surgical's stock is owned by many different institutional and retail investors. Top institutional shareholders include VK Services LLC (48.59%), Comprehensive Financial Management LLC (5.19%), Ghisallo Capital Management LLC (0.23%), Raymond James & Associates (0.17%), Chase Investment Counsel Corp (0.08%) and Credit Suisse AG (0.07%).

Which major investors are buying Vicarious Surgical stock?

RBOT stock was acquired by a variety of institutional investors in the last quarter, including VK Services LLC, Comprehensive Financial Management LLC, Ghisallo Capital Management LLC, Raymond James & Associates, Chase Investment Counsel Corp, Credit Suisse AG, Citadel Advisors LLC, and Wolverine Trading LLC.

How do I buy shares of Vicarious Surgical?

Shares of RBOT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Vicarious Surgical's stock price today?

One share of RBOT stock can currently be purchased for approximately $12.80.

How much money does Vicarious Surgical make?

Vicarious Surgical has a market capitalization of $1.52 billion.

How many employees does Vicarious Surgical have?

Vicarious Surgical employs 3 workers across the globe.

What is Vicarious Surgical's official website?

The official website for Vicarious Surgical is d8holdingscorp.com.

Where are Vicarious Surgical's headquarters?

Vicarious Surgical is headquartered at 10/F CHAMPION TOWER 3 GARDEN ROAD, CENTRAL K3, .

How can I contact Vicarious Surgical?

Vicarious Surgical's mailing address is 10/F CHAMPION TOWER 3 GARDEN ROAD, CENTRAL K3, . The company can be reached via email at [email protected].


This page was last updated on 11/28/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.